Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,749 | 75,948 | 4,364 | 11,100 | N/A |
| TOTAL | $39,726 | $76,873 | $4,506 | $12,585 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 186 | 25 | 24 | 197 | N/A |
| Other Non-Current Assets | 200 | 0 | 0 | 40 | 0 |
| TOTAL | $386 | $25 | $24 | $237 | $N/A |
| Total Assets | $40,112 | $76,898 | $4,530 | $12,822 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,756 | 0 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,017 | 997 | 644 | 700 | 0 |
| Accrued Expenses | 2,326 | 912 | 678 | 580 | N/A |
| TOTAL | $9,100 | $1,910 | $1,528 | $1,909 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,205 | 9,741 | N/A | 0 | N/A |
| TOTAL | $7,205 | $9,741 | $N/A | $N/A | $N/A |
| Total Liabilities | $16,305 | $11,651 | $1,528 | $1,909 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 1 | 0 | 0 | N/A |
| Retained earnings | -112,832 | -69,675 | -58,856 | -43,839 | N/A |
| Other shareholders' equity | 0 | 0 | 57,489 | 51,052 | 0 |
| TOTAL | $23,807 | $65,247 | $3,002 | $10,914 | $N/A |
| Total Liabilities And Equity | $40,112 | $76,898 | $4,530 | $12,822 | $0 |